Literature DB >> 9086545

One-point measurement of the peak-to-peak pulsatility index as an indicator for evaluation of infrainguinal bypass procedures.

Y Inoue1, T Iwai, T Kubota, N Kure, Y Muraoka, M Endo.   

Abstract

While duplex scanning has been advocated as the most accurate modality for postoperative graft surveillance, it is time-consuming for evaluating the entire graft. The aim of the present study was to determine which parameter predicts graft failure most simply and precisely, by examining 62 men and 1 woman who collectively underwent 71 infrainguinal arterial bypasses. A total of 212 scannings were obtained using a duplex scanner, and the peak systolic velocity (PSV), PSV ratio, and peak-to-peak pulsatility index (PPI) were analyzed. This analysis revealed 7 occlusions, 9 stenoses, and 1 arteriovenous fistula. When a PSV < 45 cm/s and/or a PSV ratio > 2.0 was defined as graft failure the sensitivity was 84.0% and the specificity was 81.8%: however, a PPI < 7.0 at the midgraft, indicating graft failure, showed a sensitivity of 100% and a specificity of 83.3%. The PPI exhibited better sensitivity and specificity than the PSV, even though the PPI needs only to be measured at the midgraft whereas the PSV should be measured at at least two points. Thus, we believe that the PPI could be the most useful and simple parameter to assess infrainguinal bypass grafts.

Entities:  

Mesh:

Year:  1997        PMID: 9086545     DOI: 10.1007/bf00941803

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  20 in total

1.  The importance of routine surveillance of distal bypass grafts with duplex scanning: a study of 379 reversed vein grafts.

Authors:  J L Mills; E J Harris; L M Taylor; W C Beckett; J M Porter
Journal:  J Vasc Surg       Date:  1990-10       Impact factor: 4.268

2.  Initial experience with color-flow duplex scanning of infrainguinal bypass grafts.

Authors:  G L Londrey; K J Hodgson; D P Spadone; D E Ramsey; L D Barkmeier; D S Sumner
Journal:  J Vasc Surg       Date:  1990-09       Impact factor: 4.268

3.  Color flow duplex screening of infrainguinal grafts combining low- and high-velocity criteria.

Authors:  J G Sladen; J D Reid; P L Cooperberg; P B Harrison; T M Maxwell; M O Riggs; L D Sanders
Journal:  Am J Surg       Date:  1989-08       Impact factor: 2.565

4.  Early detection of stenosis of femoro-distal grafts. A surveillance study using colour-duplex scanning.

Authors:  B Disselhoff; J Buth; J Jakimowicz
Journal:  Eur J Vasc Surg       Date:  1989-02

5.  Revision of failed infrainguinal bypass graft: principles of management.

Authors:  R M Green; K Ouriel; J J Ricotta; J A DeWeese
Journal:  Surgery       Date:  1986-10       Impact factor: 3.982

6.  Biologic fate of autogenous vein implants as arterial substitutes: clinical, angiographic and histopathologic observations in femoro-popliteal operations for atherosclerosis.

Authors:  D E Szilagyi; J P Elliott; J H Hageman; R F Smith; C A Dall'olmo
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

7.  Does correction of stenoses identified with color duplex scanning improve infrainguinal graft patency?

Authors:  M A Mattos; P S van Bemmelen; K J Hodgson; D E Ramsey; L D Barkmeier; D S Sumner
Journal:  J Vasc Surg       Date:  1993-01       Impact factor: 4.268

8.  Observations on the use of thrombolytic agents for thrombotic occlusion of infrainguinal vein grafts.

Authors:  M Belkin; M C Donaldson; A D Whittemore; J F Polak; C J Grassi; D P Harrington; J A Mannick
Journal:  J Vasc Surg       Date:  1990-02       Impact factor: 4.268

9.  Impact of a color-flow duplex surveillance program on infrainguinal vein graft patency: a five-year experience.

Authors:  M M Idu; J D Blankenstein; P de Gier; E Truyen; J Buth
Journal:  J Vasc Surg       Date:  1993-01       Impact factor: 4.268

10.  Color-flow duplex criteria for grading stenosis in infrainguinal vein grafts.

Authors:  J Buth; B Disselhoff; C Sommeling; L Stam
Journal:  J Vasc Surg       Date:  1991-12       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.